Mesirow Financial Investment Management, Inc.
Q1 2020 13F-HR Holdings
Net value change ($000)
-7,815
(-33.0%)
New positions
22
Sold out positions
16
Turnover %
67.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ATLAS TECHNICAL CONSULTANTS | 321 | NEW |
| GTLS | 313 | NEW |
| Flexion Therapeutics Inc | 300 | NEW |
| CDNA | 281 | NEW |
| CHCT | 278 | NEW |
| ZYXIQ | 266 | NEW |
| ZIX CORP | 255 | NEW |
| CHANNELADVISOR CORP | 251 | NEW |
| VCEL | 249 | NEW |
| MBUU | 246 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| CSTL | -531 | -100.0% |
| RJET | -459 | -100.0% |
| CARROLS RESTAURANT GROUP, INC. | -449 | -100.0% |
| TALO | -445 | -84.1% |
| FBK | -400 | -100.0% |
| EVERBRIDGE, INC. | -396 | -100.0% |
| DZS INC. | -396 | -100.0% |
| LMNR | -392 | -100.0% |
| CARA THERAPEUTICS INC | -341 | -100.0% |
| DLTH | -338 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|